Inhibition of myopia development in chicks using himbacine: a role for M4 receptors?

Authors:
  • HTHue-Trung Truong
    Hue-Trung Truong
  • NMNeville A. McBrien
    Neville A. McBrien

Abstract
The success of the M1-selective muscarinic antagonist pirenzepine in preventing myopia development in animal models implicates a role for the M1 receptor. However, the relatively high dose of pirenzepine required may indicate that the drug acts through another receptor subtype. This study examined whether the M4-selective antagonist, himbacine, could also prevent myopia. Daily intravitreal injections of himbacine inhibited the inducement of myopia in chick eyes in a dose- dependent manner. Doses ≤ 200 μg caused no significant inhibition of induced myopia compared to controls (−13.7 ± 2.3 vs −16.2 ± 0.9D, ANOVA p = 0.37), whilst a dose of 800 μg almost completely inhibited the induced myopia (−2.4 ± 2.0, p < 0.01). Findings demonstrate himbacine is effective at preventing the development of myopia in chick and implicates a role for the M4 receptor.

This publication has 10 references indexed in Scilit: